Concepedia

Arijit Chakravarty

AC

Statistics

Publications

31

Citations

1.5K

H-Index

22

Active since

2004

Affiliations

Millennium Engineering and Integration (United States)(Current)

Dartmouth College

Boston University

Boston Children's Hospital

University of Washington

Arijit Chakravarty is an author at Millennium Engineering and Integration (United States) specializing in pharmacology, medicine, and life sciences.

Publications per year

2004–2023

31

Publications

31

Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel <i>In Vivo</i> Pharmacodynamic Assays

Mark Manfredi, Jeffrey Ecsedy, Arijit Chakravarty et al. · Clinical Cancer Research · 2011 · 302 citations

Medicine, Oncology, Pharmacology +14

MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy

Kara M. Hoar, Arijit Chakravarty, Claudia Rabino et al. · Molecular and Cellular Biology · 2007 · 202 citations · Full text

Life Sciences, Cell Biology, Oncology +17

SCOPE: a web server for practical de novo motif discovery

Jonathan M. Carlson, Arijit Chakravarty, Charles E. DeZiel et al. · Nucleic Acids Research · 2007 · 105 citations · Full text

Life Sciences, Bioinformatics, Biology +14

Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein

Debra Van Egeren, Alexander Novokhodko, Madison Stoddard et al. · PLoS ONE · 2021 · 96 citations · Full text

Veterinary Medicine, Evolutionary Biology, Infectious Diseases +15

Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics

Teresa Macarulla, Andrés Cervantes, Elena Élez et al. · Molecular Cancer Therapeutics · 2010 · 86 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 31